Diabeloop WP7 : Crossover Evaluation of the Safety and the Efficacy of Artificial Pancreas Diabeloop (WP7)

NACompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

March 30, 2017

Primary Completion Date

August 28, 2018

Study Completion Date

August 28, 2018

Conditions
Closed LoopDiabetes Mellitus, Type 1
Interventions
DEVICE

Continuous Glucose Monitoring

Collection of glucose data

DEVICE

External Insulin Pump

insulin delivery

OTHER

telemdecine

Remote follow up by care health providers team

DEVICE

The Diabeloop Software (Model predictive control)

Diabeloop is a Closed-loop (CL) system with a Model Predictive Control (MPC) algorithm reinforced by a decisional matrix, uploaded on a dedicated android smartphone linked to Dexcom CGM and a Cellnovo or Kaleido insulin patch-pump. The Diabeloop software calculates the insulin dose according to the patient's needs.

Trial Locations (12)

13000

Centre Hospitalier Universitaire, Marseille

14033

Centre Hospitalier Universitaire, Caen

25030

Centre Hospitalier Universitaire Jean Minjoz, Besançon

31400

Centre Hospitalier Universitaire, Toulouse

34295

Centre Hospitalier Universitaire, Montpellier

38700

Centre Hospitalier Universitaire, Grenoble

44000

Centre Hospitalier Universitaire, Nantes

51100

Centre Hospitalier Universitaire, Reims

54000

Centre Hospitalier Universitaire, Nancy

67000

Centre Hospitalier Universitaire, Strasbourg

69000

Centre Hospitalier Universitaire, Lyon

91100

Centre Hospitalier Sud-Francilien, Corbeil-Essonnes

All Listed Sponsors
lead

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

OTHER

NCT02987556 - Diabeloop WP7 : Crossover Evaluation of the Safety and the Efficacy of Artificial Pancreas Diabeloop (WP7) | Biotech Hunter | Biotech Hunter